Vaccination of volunteers in Belarus will begin on 1 October in double-blind, randomized and placebo-controlled clinical trials of the Sputnik V vaccine. RDIF is an investment in these clinical trials in Belarus with the participation of another hundred people who will have the opportunity to be vaccinated against coronavirus with a vaccine developed through the National Research Institute in Epidemiology and Microbiology of Gamaleya of the Russian Ministry of Health. Belarus, the first country to initiate clinical trials of the Sputnik V vaccine after being registered in Russia. 8 medical facilities decided as study centres in Belarus. Two Belarusian clinics have already won the first batches of the Sputnik V vaccine.
On 11 August, the Sputnik V vaccine evolved through the Gamaleya National Institute of Epidemiology and Microbiology Research registered through the Russian Ministry of Health and has become the world’s first registered coVID-19 vaccine founded on the human adenoviral vector platform. Sputnik V vaccine, the platform for generating human adenoviral vectors, and more main points are in sputnikvaccine. com